US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist
  • 3.100
  • +0.010+0.32%
Close Jan 17 16:00 ET
  • 3.100
  • 0.0000.00%
Post 19:58 ET
282.65MMarket Cap-6.83P/E (TTM)

Aquestive Therapeutics Key Stats

Aquestive Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.900M--
--2024/Q4-- / 13.112M--
Nov 4, 20242024/Q313.542M / 12.683M--
Aug 6, 20242024/Q220.099M / 12.380M--
May 7, 20242024/Q112.053M / 12.262M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 12.900M--
--2024/Q4-- / 13.112M--
Nov 4, 20242024/Q313.542M / 12.683M--
Aug 6, 20242024/Q220.099M / 12.380M--
May 7, 20242024/Q112.053M / 12.262M--

Unlock Free Earnings Estimates

Aquestive Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 18, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data